96 related articles for article (PubMed ID: 9720719)
1. TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia.
Lagneaux L; Delforge A; Bernier M; Stryckmans P; Bron D
Leuk Lymphoma; 1998 Sep; 31(1-2):99-106. PubMed ID: 9720719
[TBL] [Abstract][Full Text] [Related]
2. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors.
Lagneaux L; Delforge A; Bron D; Massy M; Bernier M; Stryckmans P
Br J Haematol; 1997 Jun; 97(3):612-20. PubMed ID: 9207409
[TBL] [Abstract][Full Text] [Related]
3. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME
Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168
[TBL] [Abstract][Full Text] [Related]
4. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
Schuler M; Tretter T; Schneller F; Huber C; Peschel C
Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
Lotz M; Ranheim E; Kipps TJ
J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
[TBL] [Abstract][Full Text] [Related]
8. Role of transforming growth factor-beta in chronic lymphocytic leukemia.
Israels LG; Israels SJ; Begleiter A; Verburg L; Schwartz L; Mowat MR; Johnston JB
Leuk Res; 1993 Jan; 17(1):81-7. PubMed ID: 8429683
[TBL] [Abstract][Full Text] [Related]
9. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
[TBL] [Abstract][Full Text] [Related]
10. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
[TBL] [Abstract][Full Text] [Related]
11. B-cell chronic lymphocytic leukemia: correlation of clinical stages with angiogenic cytokine expression.
Ho CL; Phyliky RL; Li CY
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):154-60. PubMed ID: 16785782
[TBL] [Abstract][Full Text] [Related]
12. B-cell chronic lymphocytic leukaemia cells express and release transforming growth factor-beta.
Kremer JP; Reisbach G; Nerl C; Dörmer P
Br J Haematol; 1992 Apr; 80(4):480-7. PubMed ID: 1581232
[TBL] [Abstract][Full Text] [Related]
13. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
14. The TGF-beta - SMAD pathway is inactivated in cronic lymphocytic leukemia cells.
Matveeva A; Kovalevska L; Kholodnyuk I; Ivanivskaya T; Kashuba E
Exp Oncol; 2017 Dec; 39(4):286-290. PubMed ID: 29284776
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients.
Lagneaux L; Delforge A; Bron D; Bosmans E; Stryckmans P
Leuk Lymphoma; 1995 Mar; 17(1-2):127-33. PubMed ID: 7773149
[TBL] [Abstract][Full Text] [Related]
16. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in B-chronic lymphocytic leukaemia.
Osorio LM; Aguilar-Santelises M
Med Oncol; 1998 Dec; 15(4):234-40. PubMed ID: 9951686
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16
Podaza E; Risnik D; Colado A; Elías E; Almejún MB; Fernandez Grecco H; Bezares RF; Borge M; Gamberale R; Giordano M
Int J Cancer; 2019 Mar; 144(5):1128-1134. PubMed ID: 30178523
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
20. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF
Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
